PARP-INHIBITORS ROLE IN THE TREATMENT OF OVARIAN CANCER

被引：0
|
作者：
Mahon, Lauren [1 ]
机构：
[1] Univ Rochester, Rochester, NY USA
来源：
ONCOLOGY NURSING FORUM | 2023年 / 50卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Incorporating PARP-inhibitors into clinical routine: A tailored treatment strategy to tackle ovarian cancer
    De Jaeghere, E.
    Vandecasteele, K.
    Claes, K.
    Makar, A.
    Tummers, P.
    Cocquyt, V.
    Denys, Hannelore
    ACTA CLINICA BELGICA, 2017, 72 (01) : 6 - 11
  • [2] PARP-inhibitors in epithelial ovarian cancer: Actual positioning and future expectations
    Vanacker, Helene
    Harter, Philipp
    Labidi-Galy, Sana Intidhar
    Banerjee, Susana
    Oaknin, Ana
    Lorusso, Domenica
    Ray-Coquard, Isabelle
    CANCER TREATMENT REVIEWS, 2021, 99
  • [3] Resistance to PARP-inhibitors in cancer therapy
    Montoni, Alicia
    Robu, Mihaela
    Pouliot, Emilie
    Shah, Girish M.
    FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [4] The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
    Gien, Lilian T.
    Mackay, Helen J.
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [5] PARP Inhibitors in Ovarian Cancer Treatment
    Spriggs, David R.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2197 - 2198
  • [6] PARP Inhibitors for the Treatment of Ovarian Cancer
    Cortesi, Laura
    Toss, Angela
    Cucinotto, Iole
    CURRENT CANCER DRUG TARGETS, 2018, 18 (09) : 877 - 893
  • [7] PARP inhibitors in the treatment of ovarian cancer
    Zeimet, Alain G.
    Wieser, Verena
    Knoll, Katharina
    Reimer, Daniel
    Marth, Christian
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (02) : 198 - 201
  • [8] PARP inhibitors in the treatment of ovarian cancer
    Alain G. Zeimet
    Verena Wieser
    Katharina Knoll
    Daniel Reimer
    Christian Marth
    memo - Magazine of European Medical Oncology, 2020, 13 : 198 - 201
  • [9] PARP-inhibitors beyond progression: A new way to manage oligometastatic ovarian cancer recurrence
    Palluzzi, E.
    Marchetti, C.
    Cappuccio, S.
    Avesani, G.
    Nardangeli, A.
    Scambia, G.
    Fagotti, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S744 - S745
  • [10] PARP-INHIBITORS BEYOND PROGRESSION: A NEW WAY TO MANAGE OLIGOMETASTATIC OVARIAN CANCER RECURRENCE
    Marchetti, C.
    Palluzzi, E.
    Cappuccio, S.
    Avesani, G.
    Nardangeli, A.
    Scambia, G.
    Fagotti, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A215 - A215
12345